Clinical Neurophysiology

The research environment at the Department of Clinical Neurophysiology has resulted in the development of groundbreaking methods such as single-fiber electromyography and improved diagnostics for patients with medically intractable epilepsy.

The research at the Department of Clinical Neurophysiology focuses on improving diagnostic and monitoring tools in neuromuscular disorders, including biomarkers and neurophysiology, both in vivo and in vitro, as well as new treatment options. Dr Punga holds several highly competitive national research grants from the Swedish Research Council and was recently awarded Göran Gustafsson's major medicine award for the research group's studies in the neuromuscular disease myasthenia gravis (MG). Dr. Punga's team has pioneered research in the field of microRNA biomarkers in MG and has several publications on this subject.

Furthermore, the research group has established an in-vitro multi-electrode chip model with the recording of 24,600 electrodes for the cultivation of muscle cells and neurons to simulate healthy and diseased states. For more information, see:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6190753/pdf/fphys-09-01424.pdf

The members of the central nervous system research group mainly focus on improving the location of epileptic foci and developing new methods in intraoperative monitoring and during intensive care.

Anna Rostedt Punga

researcher at Department of Neuroscience, Rostedt Punga: Clinical Neurophysiology

Email:
anna.rostedt.punga[AT-sign]neuro.uu.se
Telephone:
+4618-471 4941